1.6 PLN
5.10 M PLN
95.56 M PLN
About BIOGENED
Sector
CEO
Andrzej Rafal Grzegorzewski
Headquarters
Lodz
Website
Founded
1949
ISIN
PLBIOGN00018
FIGI
BBG001Z52905
Biogened SA engages in the production and distribution of pharmaceutical products and cosmetics. It operates under the brand name Dermedic. The firm also engages in the research and development in the area of dermatology. The company was founded in 1949 and is headquartered in Lodz, Poland.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of BGD is 20.0 PLN — it hasn't changed in the past 24 hours. Watch BIOGENED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NEWCONNECT exchange BIOGENED stocks are traded under the ticker BGD.
BGD stock hasn't changed in a week, the month change is a −13.04% fall, over the last year BIOGENED has showed a 11.11% increase.
BGD stock is 0.00% volatile and has beta coefficient of 0.40. Track BIOGENED stock price on the chart and check out the list of the most volatile stocks — is BIOGENED there?
Today BIOGENED has the market capitalization of 49.13 M, it has increased by 2.56% over the last week.
Yes, you can track BIOGENED financials in yearly and quarterly reports right on TradingView.
BGD net income for the last quarter is 104.53 K PLN, while the quarter before that showed 1.63 M PLN of net income which accounts for −93.59% change. Track more BIOGENED financial stats to get the full picture.
Yes, BGD dividends are paid annually. The last dividend per share was 0.50 PLN. As of today, Dividend Yield (TTM)% is 2.50%. Tracking BIOGENED dividends might help you take more informed decisions.
BIOGENED dividend yield was 2.78% in 2023, and payout ratio reached 24.10%. The year before the numbers were 3.15% and 29.06% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 22, 2024, the company has 205.00 employees. See our rating of the largest employees — is BIOGENED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOGENED EBITDA is 14.98 M PLN, and current EBITDA margin is 12.35%. See more stats in BIOGENED financial statements.
Like other stocks, BGD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOGENED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOGENED technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOGENED stock shows the neutral signal. See more of BIOGENED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.